Table 2 The effect of a single administration of 0.6, 2.5, and 10.0 mg/kg MPD on the attenuation in amplitude from baseline of P2 and N2 components during 10, 20, 30, and 40 min post-injection.
| Â | Â | VTA | NAc | PFC | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Time post-injection | 0.6 mg/kg | 2.5 mg/kg | 10.0 mg/kg | 0.6 mg/kg | 2.5 mg/kg | 10.0 mg/kg | 0.6 mg/kg | 2.5 mg/kg | 10.0 mg/kg |
P2 | 10 min | 11.0 | 57.0 | 58.0 | 21.0 | 17.0 | 56.0 | -9.0 | 21.0 | 63.0 |
| Â | 20 min | 3.0 | 36.0 | 57.0 | -12.0 | 28.0 | 61.0 | -11.0 | 38.0 | 52.0 |
| Â | 30 min | 29.0 | 32.0 | 37.0 | 10.0 | 16.0 | 53.0 | -7.0 | 43.0 | 28.0 |
| Â | 40 min | 18.0 | 30.0 | 13.0 | 31.0 | 21.0 | 34.0 | -17.0 | 35 | 29 |
N2 | 10 min | 16.0 | 51.0 | 68 | 34.0 | 62.0 | 64.0 | 37.0 | 75.0 | 82.0 |
| Â | 20 min | 4.0 | 40.0 | 61.0 | 11.0 | 48.0 | 61.0 | 9.0 | 71.0 | 78.0 |
| Â | 30 min | 37.0 | 26.0 | 50.0 | 16.0 | 55.0 | 62.0 | 43.0 | 66.0 | 77.0 |
| Â | 40 min | 30.0 | 22.0 | 41.0 | 33.0 | 49.0 | 53.0 | 29.0 | 48.0 | 69.0 |